HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease
Open accessAbstract
Physicians use portal pressure measurements in clinical practice and research but the methods are invasive, can cause complications, and are resource intensive.1-3 Herein we describe preliminary findings of the minimally invasive HepQuant-SHUNT test in the diagnosis of portal hypertension in precirrhotic and compensated cirrhotic patients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Emerging technologies assess clearance of a liver-metabolized substrate or release of proteases that reflect ECM degradation in liver.
“In liver, other emerging technologies assess either clearance of a liver-metabolized substrate (303), or release of proteases that reflect ECM degradation in liver (304).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [303]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 9 · Cited by 23
- Authors
- Wieland, A., Etzion, O., Ali, R. O., Levy, E., Kleiner, D. E., Helmke, S. M., Heller, T., & Everson, G. T.
- Affiliations
- University of Colorado Anschutz (US)
- National Institutes of Health (US)
- National Cancer Institute (US)
- HepQuant (United States) (US)
- Corresponding author
- Everson, Gregory T.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2022-04
- Volume
- 20
- Issue
- 4
- Pages
- e890-e894
- ISSN
- 1542-3565 (ISSN-L)
- PMC
- PMC8531144
- OpenAlex
- W3158114641
- Cited by
- 23
- References
- 9
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 8 · 2023: 4 · 2022: 3 · 2021: 1
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Clinical Gastroenterology and Hepatology (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Colorado
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- portal hypertension, compensated cirrhosis, chronic liver disease, non-invasive diagnosis
- MeSH terms
- Humans, Hypertension, Portal, Liver Cirrhosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
